Zhang Jinhua, Founder and Chairwoman of IASO Bio, Honored with 'China Innovative Drug Pioneer Award: 20 Years, 20 Individuals' for Cross-disciplinary Innovation and Leadership

In March 2017, Ms. Zhang Jinhua founded IASO Bio, dedicating to the R&D, production, and sales of cell-based innovative drugs with the vision of "bringing hope of cure to patients." Over the past seven years since its establishment, the company has achieved leapfrog development. Currently, IASO Bio has over 10 drug candidates in its pipeline, focusing on the innovation of hematological tumor cell therapies and antibody drugs as its foundation, while expanding into autoimmune diseases. These efforts are not only expected to fill gaps in both domestic and international markets but also have the potential to become globally leading treatments for related diseases, offering patients more effective and safer therapeutic options.

As a pioneer in China's cell-based new drug field, the first commercial product developed by Ms. Zhang JinhuaFokosu^®, was approved for marketing by the National Medical Products Administration on June 30, 2023, for the treatment of adult patients with relapsed or refractory multiple myeloma. From the approval of the Investigational New Drug (IND) application to the product launch, it took only three years and nine months. With the team's excellent execution, it achieved rapid progress and becameThe world's first commercialized fully human CAR-T product and China's first independently developed and fully self-produced CAR-T cell therapy。

As a cross-disciplinary entrepreneur, Ms. Zhang Jinhua worked as a securities lawyer for 15 years, serving as a core member of projects and providing services to hundreds of enterprises, gaining deep insights into the operational models of various industries and companies. It is this cross-disciplinary experience that has...She is able to examine the biopharmaceutical field from a unique perspective, perfectly integrating legal rigor, enforceability, and the innovation of biopharmaceuticals, paving a development path with IASO Bio characteristics.。

Meanwhile, as one of the few female founders on the list of winners for the "China New Drug Pioneer Award," Ms. Zhang JinhuaWith her resilience and endurance, she has added a new definition to the image of female entrepreneurs.At the award ceremony of the gala, Ms. Zhang Jinhua, as one of the dancers, presented a beautiful tango performance to all the guests, vividly interpreting the balance between work and life. She believes that,Gender is never a limitation, but a colorful force driving the world forward.。